eMethods Patient clustering within PCP practice
The 291 randomized patients were cared for by 159 intervention PCPs (primary care physicians) and 148 control PCPs. Due to some PCP changes initiated by patients, the number of PCPs was slightly larger than the number of patients. Five PCPs took care of two patients in the same study arm. Nine PCPs took care of two patients in different study arms. Of these, 5 PCPs treated first a control and subsequently an intervention patient. 4 PCPs treated intervention patients first and control patients afterwards. In 3 of these cases, intervention patients died before PCP training could take place. All other participating practices treated only one patient. There was no patient shift between the groups. On the other hand, due to PCP changes, 16 patients were treated by two different PCPs, and one by as many as three PCPs (but under the same treatment conditions).
Distribution of intervention elements as PCP training, patient training and monitoring is displayed in eFigure 2.
Potential clustering effects related to these observations were dealt with in sensitivity analyses of primary outcomes (eTable 6). In addition to the pre-specified confirmatory test (Welch's t-test, model I. in eTable 6) that addressed inter-group effects of change scores in the Mental Component Summary score (MCS) of the Short Form-36 Health Survey (SF-36) between ICU discharge and 6 months post-ICU, we ran six sensitivity analyses that addressed a possible clustering effect (models II.-VII.). Model II. is the linear mixed regression model. It is equivalent to a t-test but with an additional random effect (random intercept) for the PCP strata. Model II. was additionally adjusted for the covariate baseline MCS (model III.), and finally in model IV., the (pre-specified) adjustment set included age (linear), sex, ICU length of stay (LOS; linear), Charlson Comorbidity Index (linear), SF-36 PCS and MCS at baseline. Models IV.-V. are similar to models II.-IV. but limited to unique patient-PCP pairs (i.e. all patients that were treated by a PCP with more than one patient were excluded). All these sensitivity analyses robustly supported the claim of the confirmatory test -no evidence for a treatment group effect on the primary outcome.
Missing values and lost-to-follow up
In the main text and in this supplement we report the numbers of missing values for each outcome analysis in a separate column (relative to the numbers provided in the flow-chart Figure 1 ).
To address the potential impact of missing values on the primary outcome analysis we performed two sensitivity analyses. First, we imputed missing change scores, using a standard linear model with outcome change scores, and ICU lengths of stay and Charlson comorbidity index values at baseline as predictors. Next, after imputing the missing change scores, we re-ran the same test used for the confirmatory analysis (model I in eTable 6) on all 291 patients; results are presented as model VIII. in eTable 6. We also employed a nonparametric method developed by Lachin (1999) that was designed to explicitly address possible missing observations (model IX. in eTable 6; for details regarding the method see reference). These two sensitivity analyses robustly supported the result of the confirmatory test -there was no evidence for a treatment group effect on the primary outcome. high score indicates high satisfaction to the practice; 2 high score indicates high medication usage; 3 high score indicates low medication adherence (sum across 4 Items with option ("never"(0), "rarely"(1), "sometimes"(2), "frequently"(3), "always"(4)) eTable 6. Baseline Data (at ICU Discharge) on Secondary Outcome Measures, derived from patient reported questionnaires, provided as mean scores with standard deviations (SD). Data on the MUST questionnaire are provided as number and percentages of individuals with a more than low risk (score>1). intervention; c, control Anchors: 1 high score indicates high impairment, 2 high score indicates low impairment; 3 high score indicates high satisfaction to the practice; 4 high score indicates low medication adherence Ranges: a the range of possible scores is 0-37; b the range of possible scores is 9-46; c the range of possible scores is 0-50; d the range of possible scores is 10-70; e the range of possible scores is 0-10; f the range of possible scores is 0-100 g values only above 27 (inclusion criteria); h the range of possible sum scores is 0-16 (sum across 4 Items with option ("never"(0), "rarely"(1), "sometimes"(2), "frequently"(3), "always"(4 . Data of all monitoring calls to all intervention patients during the 12 month intervention period are included, broken down to single topics and urgency stratifications using a traffic light scheme as described in the Manuscript (line 166-168). As an example "nutrition" was a topic in 708 calls and had an acceptable clinical status in 85.5% of these calls. 
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